IVC -12%. Since you’ve just unblocked this person, you must wait 48 hours before renewing the block. This is the main SciClone Pharmaceuticals Inc stock chart and current price. SHANGHAI, March 3, 2021 /PRNewswire/ -- SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" or "SciClone") was officially listed today on the Main Board of The Stock … Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. A lot of stocks we follow did very well and are trending. What is 218200's official website? You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. Its development portfolio includes Angiomax, Loramyc, Neucardin, VIBATIV and Cleviprex. Aug 11, 2015 10:01 AM EDT. Sciclone Pharmaceuticals Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Some of the stocks we... SciClone Pharmaceuticals, Inc. is a pharmaceutical company. any of each other's Investing.com's posts. It may therefore take some time before it appears on our website. SciClone Stock News module provides quick insight into current market opportunities from investing in SciClone Pharmaceuticals, In. Investors may also be intrigued by the fact that SciClone isn't an overly expensive stock. Shares are trading at about 21 times trailing 12 month EPS and about 15 times Wall Street estimates … SciClone Stock News module provides quick insight into. Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk The market had a decent day on Thursday, but there was a mixed session at the end. Avoid profanity, slander or personal attacks. Global Impact of Covid-19 on Synthesis Polypeptide Drugs Market to Record Significant Revenue Growth... Comprehensive Report on Synthesis Polypeptide Drugs Market 2020 Trends, Growth Demand, Opportunities... Polypeptide Drug Market 2020 Potential Growth, Challenges, and Know the Companies List Could Potenti... Coronavirus drug maker SciClone Pharma eyes Hong Kong IPO - GlobalCapital. SciClone, based in Shanghai, has set the range of its IPO at between HK$17.2 and HK$18.8 per share. ENDP +8%.Losers: NLNK -30%. Sciclone Pharmaceuticals Inc is primarely in the business of pharmaceutical … Get today's SciClone Pharmaceuticals Inc stock price and latest SCLN news as well as SciClone real-time stock quotes, technical analysis, full financials and more. SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. The official website for 218200 is www.sciclone.com. Company profile page for SciClone Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information SciClone Pharmaceuticals, Inc. SEC Filing - Proxy Statement - Merger or Acquistion (preliminary) (PREM14A) August 02, 2017 SEC FilingsWed, Aug. 02, 2017 SciClone Pharma to be acquired by … SciClone Pharmaceuticals, Inc. (SCLN) Company Bio SciClone Pharmaceuticals provides therapies for oncology, infectious diseases, and cardiovascular disorders in China, United States, and Hong … Sign up to create alerts for Instruments, Please note that all comments are pending until approved by our moderators. MZOR -10%. Additionally, you may evaluate how the addition of SciClone Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility. It is selling 116 million shares, or 17 per cent of its enlarged share capital, to … Will Five Below (NASDAQ:FIVE) shadow Dicks Sporting price growth? It has a product portfolio of therapies for cancer and infectious diseases. We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. Thanks for your comment. It has a product portfolio of therapies for cancer and infectious diseases. The Company's lead product ZADAXIN (thymalfasin) is approved in over 30 countries, which is used for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and certain cancers according to the local regulatory approvals, and for use as an immune system enhancer. Similarly, it shows return on stockholders equity (ROE) of 0.19 %, meaning that it created $0.19 on every $100 dollars invested by stockholders.SciClone Pharmaceuticals… Get the latest SciClone Pharmaceuticals, detailed stock quotes, stock trade data, stock price info, and performance analysis, including SciClone investment advice, charts, stats and more. This is way below average. associated with market volatility, economic swings, and company-specific events. That information is available publicly through SciClone media outlets and privately through word of mouth or via SciClone internal channels. SciClone has in-licensed two … SciClone has in-licensed two … SciClone Pharmaceuticals, Inc. (US:SCLN) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. By doing so, you and %USER_NAME% will not be able to see Where are 218200's headquarters? The Company sells ZADAXIN in various international markets through its subsidiary, SciClone Pharmaceuticals International Ltd. (SPIL). The Company operates in two segments: China and the Rest of the World, including its operations in the United States and Hong Kong. SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central … Replace the attached chart with a new chart ? SCLN +8%. SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. Company Name: SciClone Pharmaceuticals Inc., Stock Symbol: SCLN, Industry: Biotechs, Total Posts: 122, Last Post: 8/22/2016 12:30:10 PM This comment has already been saved in your, Tech Rebound, Treasury Sales, Chinese Rout Hits Copper - What's up in Markets, Zoom, GameStop Rise Premarket; Stitch Fix Slumps, Nasdaq Futures Up 270 Pts; Tech Stocks Set To Rebound, 3 Stocks To Watch In The Coming Week: Tesla, Oracle, JD.Com, Week Ahead: Yields To Surge On $1.9T Stimulus, Lifting Stock Volatility, USD, 1 Stock To Buy, 1 Stock To Dump When Markets Open: Roblox, Zoom Video, Vanguard Total Bond Market II Index Fund Investor, PIMCO Commodity Real Return Strategy Institutional, SG FTSE MIB Gross TR 5x Daily Short Strategy RT 18, Vontobel 7X Long Fixed Lever on Natural Gas 8.06, Healthcare - Top 5 Gainers / Losers as of 11:00 am, U.S. shares mixed on European worries; Dow opens down 0.12%, Direxion Daily Junior Gold Miners Bull 2X Shares. Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Weak … However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion. VRX +8%. © 2007-2021 Fusion Media Limited. You can analyze the entity against its peers and financial market as a whole to determine factors that move SciClone Pharmaceuticals,'s price. They have focused their current product development and … Post-Market 0.00 (0.00%) SciClone Pharmaceuticals, has return on total asset (ROA) of 0.16 % which means that it generated profit of $0.16 on every $100 spent on asset. Gainers: CHRS +11%. By TheStreet Wire. Your ability to comment is currently suspended due to negative user reports. FOSTER CITY, Calif., June 8, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) (the "Company" or "SciClone") and a consortium consisting of entities affiliated … Alvexo - What is Short selling and short squeezing? One share of SCLN stock can currently be purchased for approximately $11.15. SciClone Pharmaceuticals Inc stock rating and analysis - : a summary of key financial strength and profitability metrics. SciClone Pharmaceuticals, Inc. (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock … Use historical and current headlines to determine the investment … Find the latest 218200 (SCLN) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock Screener Top Stocks by Target Price Dividend Discount Model Stock Valuation Industry Rank Best ETFs "A" Rated ETFs Best ETF Categories ... SciClone Pharmaceuticals, Inc. (SCLN): … Please wait a minute before you try to comment again. CORT -9%. %USER_NAME% was successfully added to your Block List. There is far too much social signal, news, headlines, and media speculation about SciClone Pharmaceuticals, that is available to investors today. Economic Events and content by followed authors, Write your thoughts about SciClone Pharmaceuticals Inc. Are you sure you want to delete this chart? Are you sure you want to block %USER_NAME%? However, regardless of the origin, that wast amount of SciClone data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field. The stock market had a difficult session to start out the day, but it came back nicely only to roll back again at the end of the day, finishing in the red. The Company's product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. When running SciClone Pharmaceuticals, stock analysis, check to measure SciClone Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. Most of SciClone Pharmaceuticals,'s stock examination focuses on studying past and present price action to predict the probability of SciClone Pharmaceuticals,'s future price movements. XXII +8%. View, What are the Cantel Medical (NYSE:CMD) projections for April. The Company's business is focused primarily in the People's Republic of China. SciClone Pharmaceuticals (SCLN) Stock: Weak On High Volume Today. On … MARKETS. What is April outlook for Avid Bioservices (NASDAQ:CDMO)? Major shareholders … Sponsored content. We have many different tools that can be utilized to determine how healthy SciClone Pharmaceuticals, is operating at the current time. SciClone Pharmaceuticals, Inc. NASDAQ Updated Oct 13, 2017 8:50 PM SCLN 11.15 0.00 (0.00%). Alvexo - How to Trade Triangles for Forex, Cyprus Securities and Exchange Commission (Cyprus), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), The European Securities and Markets Authority (Euro Zone), The Financial Conduct Authority (United Kingdom), National Commission for Companies and the Stock Exchange (Italy), Cyprus Securities and Exchange Commission (Cyprus), The National Bank of the Republic of Belarus (Belarus), The Financial Conduct Authority (United Kingdom), Cyprus Securities and Exchange Commission (Cyprus), Australian Securities and Investments Commission (Australia), International Financial Services Commission (Belize), To use this feature, make sure you are signed-in to your account, Make sure you are signed-in with the same user profile. Upgrade to remove this ad. SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Files An 8-K Completion of Acquisition or Disposition of AssetsItem 2.01 Completion of Acquisition or Disposition of Assets. All Rights Reserved. In addition to ZADAXIN, SciClone markets seven partnered and in-licensed products in China. Your status will be reviewed by our moderators.